Destruel, P.-L.; Zeng, N.; Brignole-Baudouin, F.; Douat, S.; Seguin, J.; Olivier, E.; Dutot, M.; Rat, P.; Dufaÿ, S.; Dufaÿ-Wojcicki, A.;
et al. In Situ Gelling Ophthalmic Drug Delivery System for the Optimization of Diagnostic and Preoperative Mydriasis: In Vitro Drug Release, Cytotoxicity and Mydriasis Pharmacodynamics. Pharmaceutics 2020, 12, 360.
https://doi.org/10.3390/pharmaceutics12040360
AMA Style
Destruel P-L, Zeng N, Brignole-Baudouin F, Douat S, Seguin J, Olivier E, Dutot M, Rat P, Dufaÿ S, Dufaÿ-Wojcicki A,
et al. In Situ Gelling Ophthalmic Drug Delivery System for the Optimization of Diagnostic and Preoperative Mydriasis: In Vitro Drug Release, Cytotoxicity and Mydriasis Pharmacodynamics. Pharmaceutics. 2020; 12(4):360.
https://doi.org/10.3390/pharmaceutics12040360
Chicago/Turabian Style
Destruel, Pierre-Louis, Ni Zeng, Françoise Brignole-Baudouin, Sophie Douat, Johanne Seguin, Elodie Olivier, Melody Dutot, Patrice Rat, Sophie Dufaÿ, Amélie Dufaÿ-Wojcicki,
and et al. 2020. "In Situ Gelling Ophthalmic Drug Delivery System for the Optimization of Diagnostic and Preoperative Mydriasis: In Vitro Drug Release, Cytotoxicity and Mydriasis Pharmacodynamics" Pharmaceutics 12, no. 4: 360.
https://doi.org/10.3390/pharmaceutics12040360
APA Style
Destruel, P. -L., Zeng, N., Brignole-Baudouin, F., Douat, S., Seguin, J., Olivier, E., Dutot, M., Rat, P., Dufaÿ, S., Dufaÿ-Wojcicki, A., Maury, M., Mignet, N., & Boudy, V.
(2020). In Situ Gelling Ophthalmic Drug Delivery System for the Optimization of Diagnostic and Preoperative Mydriasis: In Vitro Drug Release, Cytotoxicity and Mydriasis Pharmacodynamics. Pharmaceutics, 12(4), 360.
https://doi.org/10.3390/pharmaceutics12040360
